MyShare
Symbol search
| date | o | news | sym |
| proactiveinvestors co uk 09:09 Tue 23 OthrMvrs | OKYO Pharma higher after receiving ocular pain treatment patent A look at some of the major movers in London on Tuesday https://www.proactiveinvestors.co.uk/companies/news/942034/okyo-pharma-higher-after-receiving-ocular-pain-treatment-patent-942034.html | OKYO LSE Healt |
Text search
| date | o | news | |
| biotechblog 8h ago Nws | New patent for Exela Pharma drug ELCYS Annual Drug Patent Expirations for ELCYS Elcys is a drug marketed by Exela Pharma and is included in one NDA. It is available from one supplier. There are three patents The post New patent for Exela Pharma drug ELCYS appeared first on DrugPatentWatch ... The post New patent for Exela Pharma drug ELCYS appeared first on Biotechblog . | ||
| biotechblog 8h ago Nws | New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are The post New patent for Antares Pharma drug XYOSTED ... The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on Biotechblog . | ATRS Healt | |
| sciencedaily 12:54 Tue 2 | New study gives the most detailed look yet at the neuroscience of placebo effects A large proportion of the benefit that a person gets from taking a real drug or receiving a treatment to alleviate pain is due to an individual's mindset, not to the drug itself. Understanding the neural mechanisms driving this placebo effect has been a longstanding question. A meta-analysis finds that placebo treatments to reduce pain, known as placebo analgesia, reduce pain-related activity in multiple areas of the brain. | ||
| globenewswire 11:00 Tue 2 Nws | Oyster Point Pharma Announces FDA Acceptance for Filing New Drug Application for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye Disease PRINCETON, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for OC-01 (varenicline) nasal spray for the treatment of signs and symptoms of dry eye disease. The Prescription Drug User Fee Act (PDUFA) target action date for OC-01 (varenicline) nasal spray is October 17, 2021. At present, FDA has stated that it does not intend to hold an advisory committee meeting to discuss this application. | ||
| awesomepennystocks 9h ago Nws | Ocular Therapeutics Continues to Surge despite Headwinds Ocular Therapeutics Continues to Surge despite Headwinds Ocular Therapeutics is up 34.8% recently subsequent to declaring that the FDA’s worries with respect to the organization’s New Drug Application (NDA) seem to have been tended to. Situated in Bedford, MA, OCUL is a biopharmaceutical organization that spotlights on the improvement and commercialization of eye-consideration items. It has created DEXTENZA, a treatment intended to be directed for visual agony taking after eye-related surgery. The FDA issued a Complete Response Letter (CRL) to the organization’s NDA, refering to worries about insufficiencies in OCUL’s assembling forms that were seen amid an assessment. However there … Read More | ||
| news-medical net 13:44 Tue 2 TrdId | Study provides detailed insight into neural mechanisms underlying placebo effects A large proportion of the benefit that a person gets from taking a real drug or receiving a treatment to alleviate pain is due to an individual's mindset, not to the drug itself. | ||
| proactiveinvestors co uk 00:07 Mon 1 Nws | Archer Materials makes progress with patent applications for 12CQ quantum computing qubit processor chip Receiving the Fist Office Actions is a key step in the process for the grant of a patent in the administering jurisdiction. | ||
| globenewswire 15:45 Tue 2 Nws | SPRINT PNS System Demonstrates the Important Role of the Multifidus in Treating Recurrent Low Back Pain Following RFA Results Highlight Clinically Significant and Durable Reductions in Chronic Low Back Pain Following Treatment Results Highlight Clinically Significant and Durable Reductions in Chronic Low Back Pain Following Treatment | ||
| awesomepennystocks 03:04 Tue 2 Nws | Cerulean Pharma (CERU) Cerulean Pharma (CERU) Shares of Cerulean Pharma (CERU) were diving 53.89% to $1.26 on substantial exchanging after the organization declared its kidney malignancy drug, CRLX101, demonstrated no factual importance in a stage II clinical trial. More than 5.44 million shares of Cerulean’s stock have exchanged so far today, higher than the 30-day every day normal of 373,000 shares. The medication was tried in blend with Roche Holding’s (RHHBY) Avastin, contrasting both medications with the examiner’s decision of standard of consideration treatment in patients with cutting edge renal cell carcinoma. Notwithstanding the way that the medications demonstrated no measurable hugeness in … Read More | CERU | |
| scitechdaily 10:00 Tue 2 TrdId | New Detailed Look at the Neuroscience of Placebo Effects A large proportion of the benefit that a person gets from taking a real drug or receiving a treatment to alleviate pain is due to... The post New Detailed Look at the Neuroscience of Placebo Effects appeared first on SciTechDaily . | ||
| feedburner 21:48 Wed 3 NwsGlbl | Neoliberal 'competition' in the vaccine world. Big Pharma is fighting for tight control over Covid-19 vaccine production, limiting availability worldwide while reaping billions. The Intercept Drug Lobby Asks Biden to Punish Foreign Countries Pushing for Low-Cost Vaccines Lee Fang See also Jacobin Finland Had a Patent-Free COVID-19 Vaccine Nine Months Ago But Still Went With Big Pharma Ilari Kaila and Joona-Hermanni Mkinen Also KHN They [ Oxford University] Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to Pharma Jay Hancock | ||
| prnewswire:443 19:20 Wed 3 Nws | AMO Pharma to Participate in Myotonic Dystrophy Foundation 'Meet the DM Drug Developers' Program on March 5, 2021 LONDON, March 3, 2021 /PRNewswire/ -- AMO Pharma Limited ('AMO Pharma'), a privately held biopharmaceutical company focusing on rare, childhood onset neurogenetic disorders with limited or no treatment options, today announced that the company will participate in the 'Meet the DM Drug... | ||
| achengula 17:26 Tue 2 NwsRmrs | Does Kinesiology Treatment Work For Yeast Infections Many women struggled with yeast infections with much pain. Some of them unexpectedly stumbled upon a terrific solution. Following the treatment using kinesiology, they never have to deal with another flare up again. I heard a story that a woman was referred to a kinesiologist as she could not tolerate the intense itch and burning. […] The post Does Kinesiology Treatment Work For Yeast Infections appeared first on Virology Hub . | ||
| @OpenOutcrier 21:05 Tue 2 OthrMvrs | RECAP 3/2 Chatter (1/2)
$IGC + Cannabinoid pain patent
$FUBO - Bet Site not an official page
$BIDU + Registers EV C https://t.co/NIiWLhMY8u - | BIDU Commu | |
| techspot 12:55 Wed 3 Nws | Intel told to pay $2.2 billion in patent infringement lawsuit As reported by Bloomberg Law, a jury in Waco, Texas, ruled that Intel must pay $1.5 billion for infringement of one patent and $675 million for the second. Tom's Hardware tracked down the processor-related patents in question, finding that the '759 patent' describes clock speed management, and the '373 patent'... | INTC Techn | |
| gizmochina 09:55 Wed 3 NwsRmrs | Apple iPhones might arrive with Smart Magnetic Connectors soon: Patent Apple was recently granted a patent by the US Patent and Trademark Office. This patent was for various different types of Magnetic Smart Connector systems that might be used in the company’s iPads and iPhones. According to a PatentlyApple report, the Cupertino based giant has patented various styles of smart connectors. This patent arrives despite […] The post Apple iPhones might arrive with Smart Magnetic Connectors soon: Patent appeared first on Gizmochina . | AAPL Techn | |
| @the_hindu 02:19 Wed 3 Nws | RT @TheHinduScience: Dr Deepak Ravindran on his book The Pain-Free Mindset and longcovid treatment https://t.co/HktUFkXApJ - | ||
| prnewswire:443 17:10 Tue 2 | United States Patent Office Awards Canadian Start-up a Patent to Diagnose Migraine Using Machine Learning TORONTO, March 2, 2021 /PRNewswire/ - A new patent is poised to help migraine sufferers. Scientists have been searching for a brain wave test for migraine for 75 years, but the signals were too complicated to decode until the recent application of machine learning. U.S. Patent 10,932,725... | ||
| patentblog kluweriplaw 08:39 Wed 3 Nws | Early Disclosures of Patent Filing Activities Related to COVID-19 As of February 2021, it is still too early to have a clear and complete view of how the COVID-19 health, economic, and social crisis has affected patent filing trends and how innovation specifically dedicated to cope with the present new normal situation is the object of patent protection. This pandemic has prompted patent offices... Continue reading | ||
| benzinga 19:27 Mon 1 Nws | PLx Pharma Shares Rally After FDA Approves Supplemental New Drug Application PLx Pharma Inc (NASDAQ: PLXP ) shares were trading higher Monday after the company announcedthat the U.S. Food and Drug Administration approved a supplemental new drug application for its lead products Vazalore 325 mg and Vazalore85 mg, the first novel, liquid-filled aspirin capsule. read more | ||
| suasnews 05:42 Mon 1 Nws | Red Cat Receives Notice of Patent Issuance Supporting Commercial Product Portfolio Red Cat Holdings, Inc. (OTCQB:RCAT) (“Red Cat” or the “Company”), a leading brand in the drone industry, announced that its wholly owned subsidiary, Fat Shark Holdings, has received notice that the US Patent Office has approved its patent application covering the optical architecture of its FPV (first person view) headsets.The technology underlying this patent enables […] | ||
| pharmapathway 16:40 Mon 1 Nws | Mankind Pharma Limited-Openings for Officer/ Sr. Officer-IPQA-Apply Now Mankind Pharma Limited-Openings for Officer/ Sr. Officer-IPQA-Apply Now Job Description Note: Candidates must have exposure to Pharma manufacturing (USFDA) approved organization. Quality Assurance- Formulation (OSD) Designation:Officer/ Sr. Officer Qualification:B. Pharma / M. Pharma Experience:2-6 years Location:Paonta Sahib Openings :02 Key Responsibility: Preparation, Review and Issuing control of BMR & BPR. In-process monitoring during Dispensing, Manufacturing, […] | MNKD Healt | |
| proactiveinvestors 15:02 Wed 3 | BetterLife Pharma hires Eurofins CDMO to manufacture LSD derivative TD-0148A BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) has entered an agreement with Eurofins CDMO (contract development and manufacturing organization) Alphora Inc for the manufacturing of its LSD derivative molecule, TD-0148A, the company announced Wednesday. TD-0148A is a second-generation lysergic acid diethylamide (LSD) derivative molecule, 2-bromo-LSD, that BetterLife believes will mimic the projected therapeutic potential of LSD, without causing its undesirable psychoactive dissociative side effects, such as hallucinations. Eurofins CDMO will conduct process development, scale-up and GMP (good manufacturing practice) manufacturing of TD-0148A at its plant facility in Mississauga, Ontario. The manufacturing will be based on BetterLifes proprietary process that does not involve any controlled substances, the company said. READ: BetterLife Pharma files patent protection for its newest compound TD-010 to treat anxiolytic-use disorder Following our recent acquisition of Transcend Biodynamics, we are pleased to be moving rapidly ahead with the manufacturing program of TD-0148A for treatment of major depressive disorders and other indications, BetterLife CEO Ahmad Doroudian said in a statement. We look forward to working with Eurofins CDMO to bring this treatment to patients as quickly as possible as we prepare for our IND. BetterLife acquired Transcend for C$10 million in December, adding its LSD derivative BOL-148 to BetterLifes drug pipeline. We are pleased to be partnering with Eurofins CDMO in the proprietary manufacturing of TD-0148A, Doroudian said. We believe our novel manufacturing process and product is a significant step forward in bringing non-hallucinogenic psychoactive drugs to patients in need. Eurofins CDMO with its state-of-the-art manufacturing plant and agile team is an ideal partner to help realize our vision. Earlier this year, BetterLife announced a partnership with Eurofins CDMO for pharmacology studies of TD-0148A. We are thrilled to be partnering with BetterLife to develop and manufacture their novel and transformative therapeutic for the treatment of various neuro-psychiatric disorders, Eurofins CDMO Business Development Executive Stefan Soderman said. Eurofins CDMOs expertise, quality, and flexibility in process development, scale-up and cGMP manufacturing make us uniquely qualified to fulfill the contract development and manufacturing role for such an innovative product. Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com Follow him on Twitter @andrew_kessel | ||
| prnewswire:443 1h ago Nws | China grants Lleida.net its fifth patent MADRID, March 4, 2021 /PRNewswire/ -- The intellectual property authority of the People's Republic of China have granted Lleida.net its fifth patent in that Asian country. The patent, which is valid for a period of 20 years, corresponds to Lleida.net's method for certifying an electronic... | ||
| prnewswire:443 10:30 Wed 3 Nws | Nanoscope President to Deliver Talk on Gene Therapy for Retinal Diseases at Association for Ocular Pharmacology and Therapeutics Conference BEDFORD, Texas, March 3, 2021 /PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for treatment of inherited retinal diseases, today announced that its President, Samarendra Mohanty, Ph.D., will participate in the Association for... | ||
| feedburner 13:35 Wed 3 Nws | Ciari Guitars won a patent for their 'Foldable Stringed Guitar' that uses software on an iPhone to auto-tune the Guitar & more Over the weekend I stumbled across a granted patent issued to Ciari Guitars by the US Patent & Trademark Office on February 25 2021. The patent is for a foldable stringed guitar. What struck me about the invention was that it mentioned software running on an iPhone or iPad. | AAPL Techn | |
| gizchina 14:15 Wed 3 TrdId | Huawei remains the worlds highest 5G patent holder Qualcomm is catching up In February of this year, IPLytics, a world-renowned patent data company, released a report on “Who Is Leading the 5G Patent Race?”. The report captures ... The post Huawei remains the world’s highest 5G patent holder – Qualcomm is catching up appeared first on Gizchina.com . | QCOM Techn | |
| prnewswire:443 18:43 Tue 2 Nws | Pinnacle Treatment Centers Opens Brilliant Treatment Services to provide opioid addiction treatment for community BRILLIANT, Ohio, March 2, 2021 /PRNewswire/ -- Pinnacle Treatment Centers, a leader in providing accessible, affordable treatment for individuals struggling with substance abuse, has opened Brilliant Treatment Services in Jefferson County, Ohio. Located at 1479 3rd Street in Brilliant,... | ||
| teslarati 06:35 Wed 3 | Tesla closes in on Tuscan, Slate Solar Roof tiles with camouflaged solar panel patent Tesla was issued a patent for camouflaged solar panels recently. The patent hints that Tesla may be close to releasing other Solar Roof variants like the Tuscan and Slate tiles Elon Musk talked about several years ago. The latest Tesla solar roof patent was issued on March 2, 2021. The patent describes how Tesla has […] The post Tesla closes in on Tuscan, Slate Solar Roof tiles with camouflaged solar panel patent appeared first on TESLARATI . | TSLA Consu | |
| americanbankingnews 14:46 Mon 1 OthrMvrs | PLx Pharma (NASDAQ:PLXP) Shares Gap Up to $7.43 PLx Pharma Inc. (NASDAQ:PLXP) shares gapped up prior to trading on Monday . The stock had previously closed at $7.43, but opened at $9.24. PLx Pharma shares last traded at $7.88, with a volume of 91,843 shares trading hands. Separately, Zacks Investment Research upgraded PLx Pharma from a “sell” rating to a “hold” rating in […] | PLXP Healt |